لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Koster BD; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., López González M; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Hout MF; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Turksma AW; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sluijter BJ; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Molenkamp BG; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Leeuwen PA; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vosslamber S; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Scheper RJ; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Eertwegh AJ; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Tol MP; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jordanova EJ; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands td.degruijl@amsterdamumc.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Dendritic Cells/*drug effects , Lectins, C-Type/*metabolism , Lipopolysaccharide Receptors/*metabolism , Lymphocytes, Tumor-Infiltrating/*drug effects , Melanoma/*drug therapy , Oligodeoxyribonucleotides/*administration & dosage , Receptors, Mitogen/*metabolism , Skin Neoplasms/*drug therapy , T-Lymphocytes/*drug effects , Thrombomodulin/*metabolism, Adult ; Aged ; Cells, Cultured ; Clinical Trials, Phase II as Topic ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Female ; Humans ; Injections, Intradermal ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Male ; Melanoma/immunology ; Melanoma/metabolism ; Middle Aged ; Neoplasm Staging ; Randomized Controlled Trials as Topic ; Skin Neoplasms/immunology ; Skin Neoplasms/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Time Factors ; Treatment Outcome ; Tumor Microenvironment

المؤلفون: Koster BD; Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., de Jong TD; Departments of Rheumatology, Amsterdam UMC, Vrije Universiteit, Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands., van den Hout MFCM; Departments of Pathology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sluijter BJR; Departments of Surgical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., Vuylsteke RJCLM; Departments of Surgical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., Molenkamp BG; Departments of Surgical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., Vosslamber S; Departments of Rheumatology, Amsterdam UMC, Vrije Universiteit, Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands., van den Tol MP; Departments of Surgical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van den Eertwegh AJM; Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., de Gruijl TD; Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2019 Dec 26; Vol. 9 (1), pp. 1708066. Date of Electronic Publication: 2019 Dec 26 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology

مواضيع طبية MeSH: Granulocyte-Macrophage Colony-Stimulating Factor*/therapeutic use , Melanoma*/drug therapy, Dendritic Cells ; Female ; Humans ; Male ; Sex Factors

المؤلفون: van den Hout MFCM; Department of Pathology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands.; Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Koster BD; Department of Medical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., Sluijter BJR; Department of Surgical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., Molenkamp BG; Department of Surgical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., van de Ven R; Department of Medical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., van den Eertwegh AJM; Department of Medical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., Scheper RJ; Department of Pathology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., van Leeuwen PAM; Department of Surgical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., van den Tol MP; Department of Surgical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands., de Gruijl TD; Department of Medical Oncology, VU University Medical Center/Cancer Center Amsterdam, De Boelelaan, Amsterdam, the Netherlands. TD.degruijl@vumc.nl.

المصدر: Cancer immunology research [Cancer Immunol Res] 2017 Nov; Vol. 5 (11), pp. 969-977. Date of Electronic Publication: 2017 Sep 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Dendritic Cells/*immunology , Melanoma/*immunology , Neoplasm Recurrence, Local/*immunology , Sentinel Lymph Node/*immunology , T-Lymphocyte Subsets/*immunology, Female ; Humans ; Male ; Melanoma/pathology ; Middle Aged ; Neoplasm Staging ; Sentinel Lymph Node/pathology